The role of lipid peroxidation in individuals with autism spectrum disorders

Kunio Yui, George Imataka, Hitomi Sasaki, Ryoichi Shiroki

研究成果: Article査読

1 被引用数 (Scopus)

抄録

The role of malondialdehyde-modified low-density lipoprotein (MDA-LDL), an oxidized LDL, in the pathophysiology of autism spectrum disorder (ASD) is unclear. We studied association between MDA-LDL and behavioral symptoms in 11 individuals with ASD and 7 age -matched normal controls. Behavioral symptoms were assessed using the Aberrant Behavior Checklists (ABC). Because small sample size in this study, three measures were conducted: first, employment of adaptive Lasso for enhancing the accuracy of prediction and interpretability; second, calculation of coefficient of variation for an appropriate selection of plasma variables; and third, selection of good candidates of plasma variables. Plasma levels of MDA-LDL, eicosapentaenoic acid, docosahexaenoic acid (DHA) and DHA/arachidonic acid ratios were significantly higher, while plasma superoxide dismutase (SOD) levels were significantly lower in the ASD group than in the control group. The total ABC scores were significantly higher in the ASD group than in the control group. Multiple linear regression analysis and the adaptive Lasso revealed association of increased plasma DHA levels with the ABC total scores and increased plasma MDA-LDL levels. Such association between DHA and plasma MDA-LDL levels may contribute to behavior in individuals with ASD.

本文言語English
ページ(範囲)1101-1108
ページ数8
ジャーナルMetabolic Brain Disease
35
7
DOI
出版ステータスPublished - 01-10-2020

All Science Journal Classification (ASJC) codes

  • 生化学
  • 臨床神経学
  • 細胞および分子神経科学

フィンガープリント

「The role of lipid peroxidation in individuals with autism spectrum disorders」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル